Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | GSK3A | P49840 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 6/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16033032 | 0.91 | GGPS1 (0.48) | CYP19A1MAPK1SRCEP300L3MBTL1 | |
| SCHEMBL14788175 | 0.88 | MAPK1 (0.51) | MAPK1SRCPKMATMHSD17B10 | |
| SCHEMBL14104171 | 0.87 | SRC (0.43) | MAPK1SRCPKMATMHSD17B10 | |
| SCHEMBL16612622 | 0.86 | MAPK1 (0.46) | MAPK1SRCPKMATMHSD17B10 | |
| SCHEMBL16612208 | 0.85 | MAPK1 (0.45) | MAPK1SRCPKMATMHSD17B10 | |
| SCHEMBL15121329 | 0.85 | SRC (0.47) | MAPK1SRCPKMATMHSD17B10 | |
| SCHEMBL23069274 | 0.85 | CYP19A1 (0.42) | CYP19A1SRCNPSR1L3MBTL1 | |
| SCHEMBL23069258 | 0.85 | CYP19A1 (0.42) | CYP19A1SRC | |
| SCHEMBL12847886 | 0.84 | SRC (0.44) | MAPK1SRCPKMATMHSD17B10 | |
| SCHEMBL18079400 | 0.83 | EP300 (0.55) | CYP19A1EP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220324770-A1 | NITRIFICATION INHIBITORS | THE UNIVERSITY OF MELBOURNE (AU) | 2022-10-13 | — | — | US | claimed |
| EP-4025564-A1 | NITRIFICATION INHIBITORS | The University of Melbourne (AU) | 2022-07-13 | — | — | EP | claimed |
| CN-114616227-A | Nitrification inhibitors | 墨尔本大学 | 2022-06-10 | — | — | CN | claimed |
| WO-2021042169-A1 | NITRIFICATION INHIBITORS | THE UNIVERSITY OF MELBOURNE (AU) | 2021-03-11 | — | — | WO | claimed |
| CN-114616227-B | Nitrification inhibitor | 墨尔本大学 | 2025-01-21 | — | — | CN | disclosed |
| US-20220324770-A1 | NITRIFICATION INHIBITORS | THE UNIVERSITY OF MELBOURNE (AU) | 2022-10-13 | — | — | US | disclosed |
| EP-4025564-A1 | NITRIFICATION INHIBITORS | The University of Melbourne (AU) | 2022-07-13 | — | — | EP | disclosed |
| CN-114616227-A | Nitrification inhibitors | 墨尔本大学 | 2022-06-10 | — | — | CN | disclosed |
| WO-2021042169-A1 | NITRIFICATION INHIBITORS | THE UNIVERSITY OF MELBOURNE (AU) | 2021-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220324770-A1 | NITRIFICATION INHIBITORS | NOS1, NOS2, NIT2 | CYP19A1 175/4885MAPK1 1309/4885SRC 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.